All lobbying filings

AVENUE SOLUTIONS

Lobbying for EDWARDS LIFESCIENCES LLC · Patient-focused innovations for structural heart disease and critical care monitoring

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $50,000.00 income · posted Jul 21, 2025

Official filing document

Bills named in this filing 3

S 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
HCONRES 14
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appro…

Lobbying activity 1

Medicare/Medicaid

Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14. (Public Law No: 119-21)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.